PL376716A1 - Podstawiona 4-amino-1-(pirydylometylo) piperydyna i związki pokrewne - Google Patents

Podstawiona 4-amino-1-(pirydylometylo) piperydyna i związki pokrewne

Info

Publication number
PL376716A1
PL376716A1 PL376716A PL37671603A PL376716A1 PL 376716 A1 PL376716 A1 PL 376716A1 PL 376716 A PL376716 A PL 376716A PL 37671603 A PL37671603 A PL 37671603A PL 376716 A1 PL376716 A1 PL 376716A1
Authority
PL
Poland
Prior art keywords
pyridylmethyl
piperidine
amino
substituted
receptor antagonists
Prior art date
Application number
PL376716A
Other languages
English (en)
Inventor
Mathai Mammen
Richard Wilson
Yan Chen
Sarah Dunham
Adam Hughes
Craig Husfeld
Yu-Hua Ji
Li Li
Trevor Mischki
Ioanna Stergiades
Original Assignee
Theravance, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance, Inc. filed Critical Theravance, Inc.
Publication of PL376716A1 publication Critical patent/PL376716A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
PL376716A 2002-10-30 2003-10-29 Podstawiona 4-amino-1-(pirydylometylo) piperydyna i związki pokrewne PL376716A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42222902P 2002-10-30 2002-10-30
US48648303P 2003-07-11 2003-07-11

Publications (1)

Publication Number Publication Date
PL376716A1 true PL376716A1 (pl) 2006-01-09

Family

ID=32314442

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376716A PL376716A1 (pl) 2002-10-30 2003-10-29 Podstawiona 4-amino-1-(pirydylometylo) piperydyna i związki pokrewne

Country Status (20)

Country Link
US (2) US7285564B2 (pl)
EP (1) EP1556372B1 (pl)
JP (2) JP4448492B2 (pl)
KR (1) KR20050061504A (pl)
AR (1) AR041855A1 (pl)
AT (1) ATE363482T1 (pl)
AU (1) AU2003285100A1 (pl)
BR (1) BR0315778A (pl)
CA (1) CA2500800A1 (pl)
DE (1) DE60314170T2 (pl)
EC (1) ECSP055762A (pl)
ES (1) ES2287543T3 (pl)
IS (1) IS7780A (pl)
MX (1) MXPA05004507A (pl)
NO (1) NO20052521L (pl)
PE (1) PE20040606A1 (pl)
PL (1) PL376716A1 (pl)
RU (1) RU2005116239A (pl)
TW (2) TWI295669B (pl)
WO (1) WO2004041806A2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI295669B (en) * 2002-10-30 2008-04-11 Theravance Inc Substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds
TW200510298A (en) 2003-06-13 2005-03-16 Theravance Inc Substituted pyrrolidine and related compounds
WO2005007645A1 (en) * 2003-07-11 2005-01-27 Theravance, Inc. Substituted 4-amino-1-benzylpiperidine compounds
PE20050973A1 (es) * 2003-10-29 2005-11-19 Theravance Inc Sales de acido naftalen-1,5-disulfonico de un compuesto de 4-amino-1-(piridilmetil)piperidina como antagonistas de receptores muscarinicos
JP2007528414A (ja) * 2004-03-11 2007-10-11 セラヴァンス， インコーポレーテッド ムスカリンレセプターアンタゴニストとしての有用なジフェニルメチル化合物
WO2005087763A1 (en) * 2004-03-11 2005-09-22 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists
TW200540154A (en) * 2004-06-10 2005-12-16 Theravance Inc Crystalline form of a substituted pyrrolidine compound
TW200628465A (en) * 2004-10-28 2006-08-16 Theravance Inc Process for preparing substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds
EP1817032A2 (en) * 2004-11-29 2007-08-15 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
US7786308B2 (en) * 2005-03-28 2010-08-31 Vertex Pharmaceuticals Incorporated Muscarinic modulators
KR101495708B1 (ko) * 2007-02-23 2015-02-25 세라밴스 바이오파마 알앤디 아이피, 엘엘씨 무스카린 수용체 안타고니스트로 유용한 4차 암모늄 디페닐메틸 화합물
WO2009153649A1 (en) * 2008-06-19 2009-12-23 Medichem, S.A. Process for preparing 3-substituted pyrrolidine compounds
BR112012007829A2 (pt) * 2009-10-07 2015-09-22 Merck Sharp & Dohme método para tratar bexiga hiperativa, e, composição farmacêutica.
US20110281853A1 (en) 2010-05-12 2011-11-17 Rishi Arora Compositions and methods for treating or preventing atrial fibrillation
AU2011285928B9 (en) * 2010-08-03 2018-08-02 B3Ar Therapeutics, Inc. Combinations of beta - 3 adrenergic receptor agonists and muscarinic receptor antagonists for treating overactive bladder
US9907767B2 (en) 2010-08-03 2018-03-06 Velicept Therapeutics, Inc. Pharmaceutical compositions and the treatment of overactive bladder
US9522129B2 (en) 2010-08-03 2016-12-20 Velicept Therapeutics, Inc. Pharmaceutical Combination
WO2013119910A1 (en) * 2012-02-09 2013-08-15 Altherx, Inc. Combination of muscarinic receptor antagonists and beta- 3 adrenoceptor agonists for treating overactive bladder
US9956194B2 (en) 2014-12-03 2018-05-01 Velicept Therapeutics, Inc. Compositions and methods of using modified release solabegron for lower urinary tract symptoms
IL258856B1 (en) 2015-10-23 2024-03-01 Velicept Therapeutics Inc Zwitterion solvegron and its uses

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3192206A (en) * 1961-12-04 1965-06-29 Robins Co Inc A H 4-(omega-aminoalkyl)-3, 3-disubstitutedn-hydrocarbon-2-pyrrolidinones and corresponding-2-thionpyrrolidinones
US3192210A (en) * 1961-12-04 1965-06-29 Robins Co Inc A H 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-pyrrolidinones and 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-thionpyrrolidinones
US3192221A (en) * 1961-12-04 1965-06-29 Robins Co Inc A H 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-pyrrolidinones and 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-thionpyrrolidinones and production thereof
GB1593851A (en) 1976-10-27 1981-07-22 Gallardo Antonio Sa N-(4-piperidyl)-benzamides and pharmaceutical compositions containing them
GB1507462A (en) 1974-03-21 1978-04-12 Gallardo Antonio Sa N-heterocyclic substituted benzamides methods for their preparation and compositions containing them
US3984557A (en) * 1974-12-26 1976-10-05 A. H. Robins Company, Incorporated Antiarrhythmia compositions and methods
US4002766A (en) * 1974-12-26 1977-01-11 A. H. Robins Company, Incorporated Antiarrhythmia methods
GB1574418A (en) * 1976-11-16 1980-09-03 Anphar Sa Piperidine derivatives
GB1575310A (en) 1976-11-16 1980-09-17 Anphar Sa Piperidine derivatives
CH628885A5 (en) 1978-01-01 1982-03-31 Anphar Sa Piperidine derivative
IL76583A (en) 1984-10-19 1988-08-31 Robins Co Inc A H 1-(aminoalkyl)-alpha'alpha-diaryl pyrrolidinyl,piperidino and homopiperidino acetamides and acetonitriles and pharmaceutical compositions containing them
US4594343A (en) 1984-10-19 1986-06-10 Shanklin Jr James R 1-[(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl]-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
US4810713A (en) * 1985-12-20 1989-03-07 A. H. Robins Company, Incorporated Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl groups used in a method for allergy treatment
EP0228893A3 (en) 1985-12-20 1990-01-03 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl group in allergy treatment
US5932594A (en) * 1988-11-01 1999-08-03 Pfizer, Inc. Muscarinic receptor antagonists
US5233053A (en) * 1989-03-17 1993-08-03 Pfizer Inc. Pyrrolidine derivatives
GB8906166D0 (en) * 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
US5070087A (en) * 1989-05-08 1991-12-03 A. H. Robins Company, Incorporated Aryl(alkyland alkylene)-N-((phenoxy and phenylthio)alkyl) aminoheterocyclics as cardiovascular, anthihistaminic, antisecretory and antiallergy agents
US5028616A (en) * 1989-09-05 1991-07-02 G. D. Searle & Co. N-benzylpiperidine amides
GB8928042D0 (en) * 1989-12-12 1990-02-14 Pfizer Ltd Muscarinic receptor antagonists
US5281601A (en) * 1989-12-12 1994-01-25 Pfizer Inc. Muscarinic receptor antagonists
GB9000301D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Piperidine & pyrrolidine derivatives
US5486527A (en) * 1990-01-06 1996-01-23 Pfizer Inc. Anticholinergic agents
US5607950A (en) * 1990-01-06 1997-03-04 Pfizer Inc. Muscarinic receptor antagonists
US5750540A (en) * 1995-04-28 1998-05-12 Banyu Pharmaceutical Co., Ltd. 1,4-di-substituted piperidine derivatives
ATE205490T1 (de) * 1995-10-13 2001-09-15 Banyu Pharma Co Ltd Substituierte heteroaromatische derivate
PE92198A1 (es) 1996-08-01 1999-01-09 Banyu Pharma Co Ltd Derivados de 1,4-piperidina disustituida que contienen fluor
AU8357198A (en) 1997-07-24 1999-02-16 Mitsubishi-Tokyo Pharmaceuticals, Inc. Aminocycloalkane compounds
CA2303385A1 (en) 1997-09-18 1999-03-25 Mitsubishi-Tokyo Pharmaceuticals, Inc. Imidazoline compounds
US6319920B1 (en) 1998-02-27 2001-11-20 Syntex (U.S.A.) Llc 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives
JP2002517464A (ja) 1998-06-08 2002-06-18 アドバンスド メディスン インコーポレーテッド ムスカリン性レセプターアンタゴニスト
US6693202B1 (en) * 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
UA73543C2 (uk) * 1999-12-07 2005-08-15 Тераванс, Інк. Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором
AU783095B2 (en) * 1999-12-07 2005-09-22 Theravance Biopharma R&D Ip, Llc Carbamate derivatives having muscarinic receptor antagonist activity
SK8002003A3 (en) 2000-12-22 2004-05-04 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as M3 antagonists
AU2002238471B2 (en) 2000-12-28 2007-06-28 Almirall, S.A. Quinuclidine derivatives and their use as M3 antagonists
CN100352806C (zh) 2001-12-03 2007-12-05 弗·哈夫曼-拉罗切有限公司 作为毒蕈碱受体拮抗剂的4－哌啶基烷基胺衍生物
TWI295669B (en) 2002-10-30 2008-04-11 Theravance Inc Substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds
EP1615881A2 (en) 2003-04-01 2006-01-18 Theravance, Inc. Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
TW200510298A (en) 2003-06-13 2005-03-16 Theravance Inc Substituted pyrrolidine and related compounds
WO2005007645A1 (en) * 2003-07-11 2005-01-27 Theravance, Inc. Substituted 4-amino-1-benzylpiperidine compounds
PE20050973A1 (es) 2003-10-29 2005-11-19 Theravance Inc Sales de acido naftalen-1,5-disulfonico de un compuesto de 4-amino-1-(piridilmetil)piperidina como antagonistas de receptores muscarinicos
JP2007528414A (ja) 2004-03-11 2007-10-11 セラヴァンス， インコーポレーテッド ムスカリンレセプターアンタゴニストとしての有用なジフェニルメチル化合物
WO2005087763A1 (en) 2004-03-11 2005-09-22 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists
TW200540154A (en) 2004-06-10 2005-12-16 Theravance Inc Crystalline form of a substituted pyrrolidine compound
TW200628465A (en) 2004-10-28 2006-08-16 Theravance Inc Process for preparing substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds

Also Published As

Publication number Publication date
WO2004041806A3 (en) 2004-08-05
DE60314170D1 (de) 2007-07-12
US20080091034A1 (en) 2008-04-17
NO20052521L (no) 2005-05-25
JP4448492B2 (ja) 2010-04-07
TWI295669B (en) 2008-04-11
ES2287543T3 (es) 2007-12-16
TW200800953A (en) 2008-01-01
JP2010059214A (ja) 2010-03-18
KR20050061504A (ko) 2005-06-22
TW200418833A (en) 2004-10-01
EP1556372A2 (en) 2005-07-27
ECSP055762A (es) 2005-07-06
US20040122014A1 (en) 2004-06-24
BR0315778A (pt) 2005-09-06
DE60314170T2 (de) 2008-01-24
RU2005116239A (ru) 2006-01-27
IS7780A (is) 2005-03-31
WO2004041806A2 (en) 2004-05-21
AU2003285100A1 (en) 2004-06-07
CA2500800A1 (en) 2004-05-21
US8030502B2 (en) 2011-10-04
JP2006512408A (ja) 2006-04-13
MXPA05004507A (es) 2005-10-18
AR041855A1 (es) 2005-06-01
ATE363482T1 (de) 2007-06-15
EP1556372B1 (en) 2007-05-30
US7285564B2 (en) 2007-10-23
PE20040606A1 (es) 2004-09-08

Similar Documents

Publication Publication Date Title
IS7780A (is) Setið 4-amínó-1-(pýridýlmetýl) píperidín sem múskarínskt viðtaka mótlyf
HK1247610A1 (zh) 作為nk1拮抗劑的哌啶衍生物
AP1828A (en) Muscarinic Acetycholine receptor antagonists
IL172911A0 (en) Muscarinic acetylcholine receptor antagonists
IL172912A0 (en) Muscarinic acetylcholine receptor antagonists
AU2003301851A1 (en) Azacyclic compounds as orexin receptor antagonist
HK1073304A1 (en) Triazole derivatives as tachykinin receptor antagonists
IL165871A0 (en) Substituted quinoline CCR5 receptor antagonists
HK1081182A1 (en) Substituted piperidine compounds for use as h3 histamine receptor antagonists
AU2003261392A1 (en) M3muscarinic acetylcholine receptor antagonists
IL174846A0 (en) Muscarinic acetylcholine receptor antagonists
IL160060A0 (en) Piperidine derivatives useful as ccr5 antagonists
EP1725238A4 (en) ACETYLCHOLINE M 3 MUSCARINIC RECEPTOR ANTAGONISTS
EP1648460A4 (en) ANTAGONISTS OF MUSCARIN ACETYLCHOLIN RECEPTOR
PL370765A1 (pl) Pochodne 4-piperydynyloalkiloaminy jako antagoniści receptorów muskarynowych
AU2002356369A1 (en) Xanthine derivatives as muscarinic receptor antagonists
EP1817302A4 (en) PIPERIDINYLPIPERIDIN-tachykinin receptor Antagonist
EP1636230A4 (en) ADENOSINE A1 RECEPTOR ANTAGONISTS
GB0302094D0 (en) EP4 receptor antagonists
EP1817284A4 (en) ANTAGONISTS OF CYCLOALKYL-PIPERIDINE TACHYKININ RECEPTOR
IL165716A0 (en) Pharmaceutical compositions containing heterocyclic adenosine receptor antagonists
DK1289955T3 (da) Piperidiner til anvendelse som orexinreceptorantagonister
SI1501809T1 (sl) Derivati triazola kot antagonisti tahikininskega receptorja
AU2002340142A1 (en) Piperidine compounds as muscarinic antagonists
AU2002334103A1 (en) Azabicyclic spiroether derivatives as receptor antagonists

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)